Treating Major Depression With Yoga Mono-therapy

Description

The goal of this single-center, single-blind, randomized, controlled, parallel group, interventional trial is to evaluate antidepressant efficacy of yoga monotherapy of 12-weeks duration in 180 adults meeting diagnostic criteria for mild-to-moderate major depression at the Zuckerberg San Francisco General Hospital. Researchers will compare the yoga interventions to an education control intervention on holistic healthcare.

Conditions

Depression Mild, Depression Moderate

Study Overview

Study Details

Study overview

The goal of this single-center, single-blind, randomized, controlled, parallel group, interventional trial is to evaluate antidepressant efficacy of yoga monotherapy of 12-weeks duration in 180 adults meeting diagnostic criteria for mild-to-moderate major depression at the Zuckerberg San Francisco General Hospital. Researchers will compare the yoga interventions to an education control intervention on holistic healthcare.

Treating Major Depression With Yoga Mono-therapy: 12-Week Randomized Controlled Trial

Treating Major Depression With Yoga Mono-therapy

Condition
Depression Mild
Intervention / Treatment

-

Contacts and Locations

San Francisco

Zuckerberg San Francisco General Hospital, San Francisco, California, United States, 94110

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 18 years of age or older
  • * Able to give voluntary, informed consent
  • * English-speaking
  • * Diagnosis of clinical depression
  • * Current use of antidepressant medication
  • * Current engagement in psychotherapy
  • * Current pregnancy
  • * Significant medical issues interfering with yoga practice

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of California, San Francisco,

Sudha Prathikanti, MD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

2026-06